Respiratory syncytial virus (RSV) infections occurred more frequently than human metapneumovirus (hMPV) infections in adults with chronic underlying health conditions. The odds of RSV test positivity ...
Yes, adults can get RSV (respiratory syncytial virus). In fact, most adults have had an RSV infection at least once in their lives. This seasonal virus is so widespread that almost all of us have had ...
"This study includes CDC’s first comprehensive estimates of RSV disease burden in U.S. adults, including hospitalizations and in-hospital deaths. It demonstrates that RSV caused a substantial burden ...
New research highlights the effectiveness of RSV preF vaccines in preventing severe respiratory infections in older adults. RSV is increasingly recognized as a substantial contributor to morbidity and ...
Using a latent class analysis model, researchers demonstrated that standard test positivity rates overestimate the true prevalence of RSV due to testing inaccuracies. The hospitalization rate for ...
Recovering from respiratory syncytial virus often doesn't end when it's time to leave the hospital, even for younger adults. For months after discharge, adults young and old often live with profound ...
Wesley Self, MD, MPH, principal investigator for the IVY Network and Senior Vice President for Clinical Research at Vanderbilt University Medical Center. One shot of an RSV vaccine protects adults ...
A nationwide Danish cohort study reports cardiovascular events up to 1 year after infection, comparable to that observed with influenza. A nationwide Danish cohort study reports cardiovascular events ...
A Danish national registry trial shows the RSVpreF vaccine is highly effective at preventing severe RSV illness and related hospitalizations in older adults, offering real-world support for broader ...
Please provide your email address to receive an email when new articles are posted on . Adults aged 75 years or older should receive a protein subunit respiratory syncytial virus vaccine. Adults aged ...
One shot of an RSV vaccine protects adults aged 60 or older from RSV-associated hospitalization and critical illness during two consecutive RSV seasons, according to a study published in JAMA by the ...